Vedolizumab
CAS 943609-66-3 1 FDA-DMF supplierBiologic
Overview
Vedolizumab is a humanized monoclonal antibody used in the treatment of ulcerative colitis and Crohn's disease. It works by blocking the migration of white blood cells into the gut, thereby reducing inflammation.
Therapeutic areas
GastroenterologyImmunologyInflammation
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.